摘要 |
Methods and medical devices for treating a proliferative disorder in a subject, e.g., restenosis in a blood vessel that has been implanted with a stent, employ a bis(thio-hydrazide amide) represented by Structural Formula I or a pharmaceutically acceptable salt or solvate thereof. Y is a covalent bond or an optionally substituted straight chained hydrocarbyl group, or, Y, taken together with both >C=Z groups to which it is bonded, is an optionally substituted aromatic group. R<SUB>1</SUB>-R<SUB>4 </SUB>are independently -H, an optionally substituted aliphatic group, an optionally substituted aryl group, or R<SUB>1 </SUB>and R<SUB>3 </SUB>taken together with the carbon and nitrogen atoms to which they are bonded, and/or R<SUB>2 </SUB>and R<SUB>4 </SUB>taken together with the carbon and nitrogen atoms to which they are bonded, form a non-aromatic heterocyclic ring optionally fused to an aromatic ring. R<SUB>7</SUB>-R<SUB>8 </SUB>are independently -H, an optionally substituted aliphatic group, or an optionally substituted aryl group. Z is O or S.
|